Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Aims To 'Pierce The Rhetoric' On Generic Application Backlog

Oct 31 2016

• By Sue Sutter

Related Content

Drug Pricing Panacea Or Just PR Victory? Expedited ANDAs May Have Limited Impact

Mar 21 2016

FDA Meets ANDA Backlog Goal Early, Still Doesn't Feel Out Of Woods

Jul 12 2016

ANDA Approvals, Complete Responses Hit Record In FY 2016

Oct 12 2016

Generic User Fee Renewal Talks Faced 'Buyer's Remorse' From GDUFA I

Oct 27 2016

Generic Drug First-Cycle Approval Rates Lagging Under GDUFA I

Oct 26 2016

Additional Topics

United States Regulation Generic Drugs Drug Review BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window